Navigation Links
UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Announce Dean Kamen as the Presenter of the 2012 Lifetime Achievement Award
Date:4/11/2012

LOS ANGELES, April 11, 2012 /PRNewswire/ -- UBM Canon's Medical Design Excellence Awards (MDEA), the industry's premier awards ceremony for medical device design and innovation, has announced that Dean Kamen will present the 2012 MDEA Lifetime Achievement Award to Dr. Thomas Fogarty during the MDEA award ceremony on May 23, 2012.

(Photo: http://photos.prnewswire.com/prnh/20120411/LA84898)

(Logo: http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)

"I am pleased to announce that Mr. Kamen will be presenting Dr. Fogarty with the Lifetime Achievement Award in Philadelphia," stated Heather Thompson, Editor in Chief, Medical Device and Diagnostic Industry. "Mr. Kamen's work has revolutionized the medical device industry. It is an honor to have two medical pioneers on hand with us; making the 2012 MDEAs a momentous event."

Dean Kamen is an inventor, an entrepreneur, and advocate for science and technology. He has more than 440 U.S. and foreign patents and invented the first wearable infusion pump and the first wearable insulin pump for diabetes. Some of the many devices Mr. Kamen has worked on include the HomeChoice™ peritoneal dialysis system, Hydroflex™ surgical irrigation pump, the Crown™ stent, iBOT™
'/>"/>

SOURCE UBM Canon
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Experts Strengthen Albright Stonebridge Groups Global Reach
2. All Global Partners With HealthEngage to Provide Unique Web 2.0 Patient Insights
3. Fundamental steps needed now in global redesign of Earth system governance
4. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
5. Scholars call for global governance overhaul to ensure Earths sustainability
6. More than half of Americans doubt US global leadership in 2020
7. Global Biotechnology Industry
8. Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
9. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
10. Life Technologies to Present at Barclays Capital Global Healthcare Conference
11. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Toronto, Canada (PRWEB) May 24, 2013 ... selective barriers, and uptake or efflux transporters at the ... may be related to unbound fractions in the tissue ... understanding of these disposition challenges is required to guide ... and to identify any species-dependent variables that may impact ...
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") a publicly ... and development, sales and marketing of premium branded ... that it is awarding exclusive Vestiage territories in ... Skin Illuminating Facial Care. Qualified applicants can request ... email to info(at)vestiageinc(dot)com and putting RELUMA in the ...
(Date:5/23/2013)... , May 24, 2013 ... angefertigt – Bei der englischen ... , 91 % der Teilnehmer einer groß angelegten ... 20 % laut GINA [*] -Definition [1] als ... Menschen mit Asthma generell einer von vier Denkweisen zugeordnet ...
(Date:5/23/2013)... May 23, 2013 Venaxis, Inc. (Nasdaq:   ... on obtaining FDA clearance and commercializing its rapid, protein ... pricing of an underwritten public offering of 10,000,000 shares ... 3,500,000 shares of its common stock at an exercise ... offering price of $1.25 per share and related warrant.  ...
Breaking Biology Technology:DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3
... SHANGHAI, Feb. 28, 2011 /PRNewswire-Asia-FirstCall/ -- ShengdaTech, Inc. ("ShengdaTech" ... leading manufacturer of nano-precipitated calcium carbonate ("NPCC") in China, ... and CEO, Ms. Anhui Guo, COO and acting CFO ... attend the Rodman & Renshaw Annual China Investment Conference ...
... announces a special edition of its Key ... Disease Day 2011 , an international event to raise awareness ... Dialogue spanned two continents and provided a platform ... caregivers and healthcare providers. (Logo: http://photos.prnewswire.com/prnh/20100914/PH63692LOGO) ...
... VILLAGE, Nev., Feb. 28, 2011 PDL BioPharma, Inc. ... it has entered into a definitive settlement agreement with ... settlement agreement, PDL agreed to dismiss its claims against ... includes Genentech, Inc. (Genentech) and F. Hoffmann-La Roche Ltd ...
Cached Biology Technology:ShengdaTech to Present at Rodman & Renshaw Annual China Investment Conference in Shanghai 2Thought Leaders in Europe and US Address Challenges to Making Rare Diseases a Global Public Health Priority 2Thought Leaders in Europe and US Address Challenges to Making Rare Diseases a Global Public Health Priority 3Thought Leaders in Europe and US Address Challenges to Making Rare Diseases a Global Public Health Priority 4Thought Leaders in Europe and US Address Challenges to Making Rare Diseases a Global Public Health Priority 5PDL Settles Litigation and Resolves Other Disputes 2
(Date:5/24/2013)... Frontiers, one of the world,s largest and fastest growing ... journal, Frontiers in Physics . , A broad ... will provide an open-science and interactive web platform ... rigorously peer-reviewed articles. , Frontiers, real-time and interactive ... range of article types. With an average of three ...
(Date:5/24/2013)... scientists have focused among other factors on drugs ... is the accumulation of A-beta that causes the known plaques ... formation of A-beta is APP. Alessia Soldano and Bassem Hassan ... APPL the fruit-fly version of APP in the ... Leuven): "We have discovered that APPL ensures that brain cells ...
(Date:5/23/2013)... year, carrying more than 284 million tons of cargo, transit ... in toll fees for the Panama Canal Authority. Each time ... water are used from Gatun Lake, which is also a ... the isthmus. , However, the advent of very large ... ships at sea, has demanded change. The Panama Canal is ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3A new strategy required in the search for Alzheimer's drugs? 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3
... are involved in activating and directing other immune cells, ... over-aggressive responses of the T cell population. , Researchers ... Teff cells in order to better shape the immune ... Memorial Sloan-Kettering Cancer Center, New York, demonstrated that an ...
... barrier against infection but skin cells themselves can mount an ... (AMPs). , As overt infection in the skin is a ... help fight infection, but play a role in preventing infection ... online on June 15 in advance of print publication in ...
... scientists have developed the first-ever genomic test to predict ... to live and which patients can avoid the toxic ... potential to save thousands of lives each year by ... it, said the test's developers at Duke's Institute for ...
Cached Biology News:First-ever genomic test predicts which lung cancer patients need chemotherapy to live 2First-ever genomic test predicts which lung cancer patients need chemotherapy to live 3First-ever genomic test predicts which lung cancer patients need chemotherapy to live 4
... Rabbit Tissue Arrays contain 60 rabbit tissue samples ... contains 4 unstained slides and 1 hematoxylin and ... slide contains 15 different tissues from 4 rabbit ... per slide. Each tissue sample (or core) is ...
A univariate (peak height or area) quantitative multi-component analysis package....
... represents a major advance in liquid dispensing ... of large robotic liquid handlers into the ... accurate volumes ranging from 10mL to 2mL ... advantages not yet found in other benchtop ...
... pyruvate, 50 mg/L streptomycin sulfate, 100 mg/L ... and magnesium chloride. The use of a ... is generally attributed to early workers in ... a solution of inorganic salts designed to ...
Biology Products: